Body mass index and response to neoadjuvant chemotherapy in breast cancer patients

被引：0
作者：
Litton, J. K. [1 ]
Gonzalez, A. M. [1 ]
Warneke, C. L. [1 ]
Kau, S. [1 ]
Buzdar, A. U. [1 ]
Bondy, M. [1 ]
Mahabir, S. [1 ]
Hortobagyi, G. N. [1 ]
Brewster, A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
531
引用
收藏
页数：1
相关论文
共 50 条
[31]   RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS [J].
Solodyannikova, O. .
RADIOTHERAPY AND ONCOLOGY, 2010, 94 :S30-S30
[32]   Radionuclide evaluation of response to neoadjuvant chemotherapy in breast cancer patients [J].
Solodyannikova, O. ;
Voit, N. ;
Dzhuzha, D. ;
Sukach, G. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 :S305-S305
[33]   Response to neoadjuvant chemotherapy in patients with triple negative breast cancer [J].
Abe, E. ;
Hayashi, N. ;
Yoshida, A. ;
Hamaoka, T. ;
Yagata, H. ;
Tsugawa, K. ;
Tsunoda-Shimizu, H. ;
Suzuki, K. ;
Nakamura, S. .
CANCER RESEARCH, 2009, 69 (02) :367S-367S
[34]   Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer [J].
Kang, S. Y. ;
Jung, Y. S. ;
Kim, K. S. .
BREAST, 2011, 20 :S48-S48
[35]   The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients [J].
Ruiz, C ;
Barros, A ;
Motta, E ;
Pinotti, J .
BREAST, 1997, 6 (05) :P949-P949
[36]   The Impact of Body Mass Index on Pathological Response and Survival Outcome after Neoadjuvant Chemotherapy in Localized Bladder Cancer [J].
Mohammed, Amrallah ;
Elsayed, Fifi ;
Salem, Reham .
MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (01) :136-145
[37]   Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer [J].
Raman, Rachna ;
Mott, Sarah L. ;
Schroeder, Mary C. ;
Phadke, Sneha ;
El Masri, Jad ;
Thomas, Alexandra .
CLINICAL BREAST CANCER, 2016, 16 (06) :480-486
[38]   Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy [J].
Mathieu, M. C. ;
Mazouni, C. ;
Kesty, N. C. ;
Zhang, Y. ;
Scott, V. ;
Passeron, J. ;
Arnedos, M. ;
Schnabel, C. A. ;
Delaloge, S. ;
Erlander, M. G. ;
Andre, F. .
ANNALS OF ONCOLOGY, 2012, 23 (08) :2046-2052
[39]   Association between body mass index change during neoadjuvant chemotherapy and pathologic complete response and overall survival in patients with inflammatory breast cancer or locally advanced non-inflammatory breast cancer [J].
Kogawa, T. ;
Fouad, T. M. ;
Wei, C. ;
El-Zein, R. A. ;
Masuda, H. ;
Chavez-Mac-Gregor, M. ;
Melhem-Bertrandt, A. ;
Litton, J. K. ;
Brewster, A. M. ;
Alvarez, R. H. ;
Hortobagyi, G. N. ;
Vicente, V. ;
Ueno, N. T. ;
Theriault, R. L. .
CANCER RESEARCH, 2013, 73
[40]   Triglyceride-glucose index and triglyceride-glucose-body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy [J].
Li, Fucheng ;
Gao, Tian ;
Li, Zhaoting ;
Dou, He ;
Ba, Yuling ;
Jia, Siyuan ;
Luo, Danli ;
Xiao, Min .
TRANSLATIONAL ONCOLOGY, 2025, 53
12345